Bio Group researches and develops NK cell therapeutics using the technology of
culture method for autologous immune cells, which maintains the same quality of
cell therapy products. We are leading the universalization of NK cell
therapeutics by establishing a GMP automatic culture system that enables efficient
mass production. In addition, with the establishment of an automatic culture
system, it is possible not only to cultivate NK cells, but also to research and
develop CDMO consignment production that records and completes data, in
collaboration with institutions that need culture research.
Bio Group has conducted research and development to add not only NK cells but
also compositions obtained through NK cell culture as active ingredients to
cosmetics, and has released cosmetics containing the composition.
study was regarding (1) using the active ingredients of the culture medium
obtained during the autoimmune cell culture process as raw materials for
cosmetics or pharmaceuticals, and (2) Whether it is possible to use a culture
medium from which immune cells containing a large amount of active ingredients
such as cytokines have been removed, that is, a medium composition to be used
as an active ingredient in a cosmetic composition or pharmaceutical composition.
it has developed products that can contribute to skin immunity activation and
skin regeneration with culture ingredients optimized for activating and
amplifying NK cell culture.
NKCL Bio Group has secured a patent-exclusive license for cell culture medium
to further utilize the active ingredient as a functional cosmetics, in addition
to the previous utilization of the active ingredients of the cell culture
license refers to the right of the patent holder, etc. to exclusively use (use)
the patented invention as a business within the scope of a contract with a
third party by specifying the content, area, and period.
exclusive license secured by NKCL Bio Group is a functional cosmetic
composition obtained by the NK cell culture method and culture, and is
functionally effective for skin whitening, pigmentation removal, and wrinkle
improvement. It is now possible to expect an anti-inflammatory effect on
dermatitis caused by bites.
particular, NKCL Bio Group plans to develop various anti-inflammatory products
such as nasal sprays that emphasize the effect of relieving gastric
inflammation and expand the premium cosmetic line by specifying ‘functional
cosmetics’ through an exclusive license.
Bio Group said, “By securing a patent-exclusive license for allogeneic immune
cell therapeutics and cell culture cosmetic composition, we have
achieved solid growth in terms of technological advancement and company level
growth ahead of the completion of the GMP Automatic Culture System and NK Immune
Therapy Center. We expect that this patent-exclusive license will give a firm
identity to the ‘Immune Care Platform’ pursued by the company.”